Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Ovarian Neoplasms 3Colorectal Neoplasms 3Neoplasms, Unknown Primary 2Hereditary Breast and Ovarian Cancer Syndrome 2Carcinoma, Intraductal, Noninfiltrating 2Brain Neoplasms 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Urogenital Neoplasms 1Primary Ovarian Insufficiency 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hot Flashes 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Breast Screening 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Anatomic Stage II Breast Cancer AJCC v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Psychiatric Rehabilitation 13Therapeutics 7Early Intervention, Educational 5Yoga 4Surveys and Questionnaires 4Methods 4Saline Solution 3Mindfulness-Based Cognitive Therapy 3Mindfulness 3Esketamine 3Chemotherapy, Adjuvant 3Transcranial Direct Current Stimulation 2Melatonin 2Gabapentin 2Exercise Therapy 2Exercise 2Educational Status 2Counseling 2Control Groups 2Cognitive Behavioral Therapy 2Acupuncture Therapy 2abacavir 1Water 1Venlafaxine Hydrochloride 1Vegetables 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Tamoxifen 1Stress Mindset Measure 1Sertraline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Genetic Testing × Breast × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡